Ilan Daskal - Sep 1, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, Chief Financial Officer
Signature: /s/ Timothy S. Ernst, attorney-in-fact
Stock symbol: BIO
Transactions as of: Sep 1, 2022
Transactions value $: -$109,893
Form type: 4
Date filed: 9/6/2022, 01:22 PM
Previous filing: Jul 21, 2022
Next filing: Sep 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+455	+100.66%	$0.00	907	Sep 1, 2022	Direct	F1
transaction	BIO	Bio-Rad A Common Stock	Tax liability	-$110K	-226	-24.92%	$486.25	681	Sep 1, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Award	$0	+2.78K		$0.00	2.78K	Sep 1, 2022	Bio-Rad A Common Stock	2.78K	$0.00	Direct	F2, F3
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-455	-24.96%	$0.00	1.37K	Sep 1, 2022	Bio-Rad A Common Stock	455	$0.00	Direct	F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3	The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F4	On September 1, 2021, the reporting person was granted 1,823 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.